These genes, or "cancer dependencies," are often promising drug targets. But new research shows that many of these CRISPR screening experiments rely on components, called CRISPR/Cas9 guides ...

In the study, "Targeting the SHOC2–RAS interaction in RAS-mutant cancers," published in Nature, researchers conducted a ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

CRISPR screening uses this technology to enable thousands ... we make an engineered T-cell and use that to hunt and destroy a cancer cell without harming healthy tissue? What is the benefit ...

Preliminary research suggests that using CRISPR to treat cancer is safe in humans and could become a ... Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening ...

It was amazing,” she says. “My whole adult life up to that point I was pretty much a cancer patient." The treatment she received uses “CRISPR gene editing” to create an individualized ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial. The Lanc Onc. 2025.

A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.

CRISPR screening enables companies to discover which ... sickle cell disease, cancer, cardiovascular diseases, diabetes Editas Medicine (NASDAQ:EDIT) $276 million Sickle cell disease, beta ...